Tandem Diabetes Care (TNDM) Receivables (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Receivables came in at $140.7 million in Q1 2026, up 11.15% YoY from $126.6 million in Q1 2025, and down 15.0% on a QoQ basis from $165.5 million in Q4 2025.
Tandem Diabetes Care (TNDM) Receivables (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Receivables data on file, last reported at $140.7 million in Q1 2026.
- Quarterly Receivables rose 11.15% year-over-year to $140.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $140.7 million (up 11.15% YoY) and the FY2025 annual result came in at $173.9 million, up 51.75% from the prior year.
- Receivables declined to $140.7 million in Q1 2026, from $165.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $165.5 million in Q4 2025 to a low of $93.0 million in Q1 2024.
- A 5-year average of $114.9 million and a median of $112.8 million in 2022 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables slipped 7.99% — and 2025, when it jumped 44.43%.
- Tracing TNDM's Receivables over 5 years: stood at $114.7 million in 2022, then retreated by 7.99% to $105.6 million in 2023, then rose by 8.55% to $114.6 million in 2024, then surged by 44.43% to $165.5 million in 2025, then decreased by 15.0% to $140.7 million in 2026.
- The last three Receivables figures came in at $140.7 million (Q1 2026), $165.5 million (Q4 2025), and $125.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn | 169.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 169.96 Mn |
| Mar 31, 2026 | 140.67 Mn |
| Dec 31, 2025 | 165.49 Mn |
| Sep 30, 2025 | 125.94 Mn |
| Jun 30, 2025 | 134.54 Mn |
| Mar 31, 2025 | 126.56 Mn |
| Dec 31, 2024 | 114.59 Mn |
| Sep 30, 2024 | 113.25 Mn |
| Jun 30, 2024 | 98.12 Mn |
| Mar 31, 2024 | 92.97 Mn |
| Dec 31, 2023 | 105.56 Mn |
| Sep 30, 2023 | 105.67 Mn |
| Jun 30, 2023 | 103.56 Mn |
| Mar 31, 2023 | 95.86 Mn |
| Dec 31, 2022 | 114.72 Mn |
| Sep 30, 2022 | 112.81 Mn |
| Jun 30, 2022 | 108.36 Mn |
| Mar 31, 2022 | 94.13 Mn |
| Dec 31, 2021 | 110.73 Mn |
| Sep 30, 2021 | 87.46 Mn |